Extended-Spectrum Beta-Lactamases and Plasmid-Mediated Ampc Enzymes among Clinical Isolates of Escherichia Coli and Kebsiella Pneumoniae from Seven Medical Centers in Taiwan
Resource
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY v.50 n.5 pp.1861-1864
Journal
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
Journal Volume
v.50
Journal Issue
n.5
Pages
1861-1864
Date Issued
2006
Date
2006
Author(s)
YAN, JING-JOU
HSUEH, PO-REN
LU, JANG- JIH
CHANG, FENG-YI
SHYR, JAINN-MING
WANG, JEN-HSIEN
LIU, YUNG-CHIN
CHUANG, YIN- CHING
YANG, YI-CHUEH
TSAUR, SHYH-MING
WU, HSIU-HUNG
WU, JIUNN-JONG
Abstract
Production of extended-spectrum beta-lactamases and plasmid- mediated AmpC enzymes was investigated among 291 Escherichia coli and 282 Klebsiella pneumoniae isolates that showed decreased susceptibilities to extended-spectrum cephalosporins from seven Taiwanese medical centers. CTX -M- type and SHV-type enzymes were the most prevalent extended- spectrum beta-lactamases. CMY-2-like and DHA-1-like beta- lactamases were the most prevalent AmpC-type enzymes.
Subjects
KLEBSIELLA-PNEUMONIAE
SOUTHERN TAIWAN
IDENTIFICATION
DIVERSITY
RESISTANT
SHV